MAPK13 Human (A62254)

MAPK13 Human

Mitogen-Activated Protein Kinase 13 Human Recombinant

E.coli.

MGSSHHHHHH SSGLVPRGSH MSLIRKKGFY KQDVNKTAWE LPKTYVSPTH VGSGAYGSVC SAIDKRSGEK VAIKKLSRPF QSEIFAKRAY RELLLLKHMQ HENVIGLLDV FTPASSLRNF YDFYLVMPFM QTDLQKIMGM EFSEEKIQYL VYQMLKGLKY IHSAGVVHRD LKPGNLAVNE DCELKILDFG LARHADAEMT GYVVTRWYRA PEVILSWMHY NQTVDIWSVG CIMAEMLTGK TLFKGKDYLD QLTQILKVTG VPGTEFVQKL NDKAAKSYIQ SLPQTPRKDF TQLFPRASPQ AADLLEKMLE LDVDKRLTAA QALTHPFFEP FRDPEEETEA QQPFDDSLEH EKLTVDEWKQ HIYKEIVNFS PIARKDSRRR SGMKL.

Greater than 90% as determined by SDS-PAGE.

The MAPK13 solution (1mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.1M NaCl, 1mM DTT and 20% glycerol.

Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.

MAP kinase 13, MAP kinase p38 delta, MAPK 13, MAPK-13, MGC99536, Mitogen activated protein kinase 13, Mitogen-activated protein kinase 13, Mitogen-activated protein kinase p38 delta, MK13_HUMAN, OTTHUMP00000016282, OTTHUMP00000016283, p38 delta, P38delta, PRKM13, SAPK 4, SAPK4, Stress activated protein kinase 4, Stress-activated protein kinase 4